Drugs / Cartibeads
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06897098 | Jun 2022 → Apr 2025 overdue | — | Vanarix SA | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cartibeads | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06897098 ↗ |
| Modality | Cell therapy | “Cartibeads are engineered from autologous articular chondrocytes (from the patient's own cartilage cells).” NCT06897098 ↗ |